Measuring Muscle Strength Provides Insights Regarding Weakness in Older Adults with COPD and Stroke

The use of isokinetic dynamometers with older adults extends far beyond orthopedics, but the reliability and responsiveness of isokinetic measures in conditions like COPD and stroke are still being evaluated, report experts in Isokinetics and Exercise Science

September 30, 2020 - Amsterdam, NL – Isokinetic dynamometry is a major tool in the measurement of muscle strength in the fields of sports medicine, orthopedic and neurological rehabilitation and exercise physiology. Its use in older individuals now extends far beyond orthopedics to such conditions More...

September 30, 2020

Persons with Parkinson’s Disease Can Have a Brighter Future

In this supplement to JPD experts review management strategies that can help improve quality of life of patients living with Parkinson's disease and highlight the importance of personalized, optimal care management

September 23, 2020 - Amsterdam, NL – Well over six million people globally have been diagnosed with Parkinson's disease, which has an enormous impact on the lives of patients and their families and incurring mounting costs for society. In this special supplement to the Journal of Parkinson's Disease experts review common and vexing issues affecting people with Parkinson's disease as well as emerging concerns such as the importance of personalized care management. More...

September 23, 2020

Neurological Consequences of COVID-19: The “Silent Wave”

September 22, 2020 - Mebourne, Australia – Is the world prepared a wave of neurological consequences that may be on its way as a result of COVID-19? This question is at the forefront of research underway at the Florey Institute of Neuroscience and Mental Health. A team of neuroscientists and clinicians are examining the potential link between COVID-19 and increased risk of Parkinson’s disease, and measures to get ahead of the curve. More...

September 22, 2020

Awareness of COVID-19 in Severe Dementia Patients

Awareness of the COVID-19 outbreak and resultant depressive tendencies in patients with severe Alzheimer’s disease

September 21, 2020 - Tokyo, Japan – The ongoing coronavirus disease 2019 (COVID-19) pandemic has substantially affected patients with dementia and their caregivers. Owing to the restrictive measures taken worldwide to block the spread of COVID-19 outbreaks (including the declaration of a state of emergency in Japan), patients with dementia and their caregivers have not been able to receive the usual support and care. Therefore, this is expected to lead to adverse effects on the patients and their caregivers, and many investigators have warned about the risks [1–3]. In fact, many scheduled appointments for routine outpatients’ examinations and care services have been canceled and postponed owing to the COVID-19 outbreak. More...

September 21, 2020